Phibro Animal Health (NASDAQ:PAHC) Downgraded to Buy Rating by StockNews.com

Phibro Animal Health (NASDAQ:PAHC) was downgraded by StockNews.com from a “strong-buy” rating to a “buy” rating in a report released on Friday.

Other research analysts have also recently issued research reports about the stock. JPMorgan Chase & Co. began coverage on shares of Phibro Animal Health in a research note on Tuesday, September 10th. They set a “neutral” rating and a $22.00 target price on the stock. Bank of America lifted their target price on shares of Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a research note on Friday, August 30th. Finally, Barclays lifted their target price on shares of Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a research note on Tuesday, November 12th.

Phibro Animal Health Stock Up 1.3 %

PAHC opened at $23.21 on Friday. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.69 and a current ratio of 3.23. Phibro Animal Health has a fifty-two week low of $10.03 and a fifty-two week high of $25.98. The firm’s fifty day moving average is $23.44 and its 200 day moving average is $20.39. The stock has a market cap of $940.01 million, a price-to-earnings ratio of 53.98, a price-to-earnings-growth ratio of 0.61 and a beta of 0.51.

Institutional Trading of Phibro Animal Health

Hedge funds have recently bought and sold shares of the stock. CWM LLC lifted its stake in Phibro Animal Health by 89.8% in the 2nd quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after purchasing an additional 1,035 shares in the last quarter. Quantbot Technologies LP bought a new stake in shares of Phibro Animal Health in the 3rd quarter worth about $70,000. nVerses Capital LLC bought a new stake in shares of Phibro Animal Health in the 3rd quarter worth about $70,000. China Universal Asset Management Co. Ltd. increased its holdings in shares of Phibro Animal Health by 63.7% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock worth $88,000 after buying an additional 1,522 shares during the last quarter. Finally, Summit Securities Group LLC bought a new stake in shares of Phibro Animal Health in the 2nd quarter worth about $83,000. Hedge funds and other institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.